Roggeri, D.P. et al. 2017. Recently approved recombinant factor VIII (rFVIII) for the replacement treatment in patients with hemophilia A in Italy. Farmeconomia. Health economics and therapeutic pathways. 18, 1 (Oct. 2017). DOI:https://doi.org/10.7175/fe.v18i1.1321.